We create in vitro models that mimic disease biology as closely as possible, to allow therapeutic candidates to be tested in a context that yields meaningful data and from which decisions can be reliably taken.

Our models are designed to yield information more reflective of the true MOAs (Mechanism Of Action) and can highlight potential safety concerns early. Our approach to enhanced in vitro characterisation is in alignment with initiatives to reduce the burden of in vivo testing requirements and provide safer and more cost-effective approaches. 

Drawing on our immunology expertise, we have built an array of systems that recapitulate key immune cell functions and interactions in both health and disease. With a strong focus on novel and emerging therapeutic classes that are designed to modulate these processes, our assay platforms are applicable to oncology, auto-immunity and beyond. By constantly expanding our knowledge base and capabilities, we provide you with a comprehensive and cutting-edge suite of solutions that evolve alongside your changing needs.